This session will explore the underlying biological mechanisms contributing to neurodegenerative diseases, focusing on cellular and molecular pathways. Emphasis will be placed on the role of neuroinflammation and oxidative stress in the progression of disorders such as Alzheimer's and Parkinson's.

This track will highlight recent breakthroughs in the understanding and treatment of Alzheimer's disease. Discussions will include novel biomarkers, therapeutic strategies, and the impact of lifestyle factors on disease progression.

This session will focus on cutting-edge research and clinical practices aimed at improving the quality of life for individuals with Parkinson's disease. Topics will include pharmacological advancements, non-pharmacological interventions, and patient-centered care models.

This track will delve into the neurobiological changes associated with various forms of dementia, including Alzheimer's and vascular dementia. Presentations will cover synaptic dysfunction, neuronal loss, and the implications for therapeutic interventions.

This session will provide insights into the design, execution, and outcomes of clinical trials focused on neurodegenerative diseases. Participants will discuss challenges in recruitment, endpoint selection, and regulatory considerations.

This track will examine potential neuroprotective strategies aimed at slowing the progression of neurodegenerative diseases. Topics will include pharmacological agents, lifestyle modifications, and emerging therapies.